Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian

NCT04741828 PHASE2, PHASE3 COMPLETED

Vi-DT Typhoid vaccine is a novel vaccine. This study will be done to know the long-term protection and persistent antibody by measured the antibody titer after 2,3,4 and 5 years after immunization.

Details

Lead sponsor	PT Bio Farma
Phase	PHASE2, PHASE3
Status	COMPLETED
Enrolment	188
Start date	Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Vaccine

Interventions

• Vi-DT Typhoid Conjugate Vaccine

Countries

Indonesia